Skip to main content

Advertisement

Log in

Fungal Infections Associated with Travel

  • Epidemiological Aspects of Fungal Infection (T Chiller and J Baddley, Section Editors)
  • Published:
Current Fungal Infection Reports Aims and scope Submit manuscript

Abstract

International travel is increasing. As fungal infections associated with travel are rare diseases, they are often underestimated and misdiagnosed. Thus, updated knowledge in this area is of key importance for physicians not only for pretravel counselling but also for the management of patients upon their return. We present an update of data published in 2012 and 2013. We present an overview of epidemiological changes, especially new endemic areas, and the implications of climate and natural disasters. Through experimental and clinical data, new insights into the pathophysiology of fungal infections associated with travel have been obtained, especially for Cryptococcus spp. Recently published diagnostic tools could lead to faster and more accurate diagnosis. Lastly, recent prognostic and therapeutic data are emphasized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. • United Nations World Tourism Organization. Tourism Highlights, 2013 Edition. http://mkt.unwto.org/en/publication/unwto-tourism-highlights-2013-edition. Very informative about tourism data.

  2. •• Lortholary O, Charlier C, Lebeaux D, Lecuit M, Consigny PH. Fungal infections in immunocompromised travelers. Clin Infect Dis. 2012;56(6):861–9. Review about immunocompromised traveler with useful diagnostic scheme.

    Article  PubMed  Google Scholar 

  3. • Leder K, Torresi J, Libman MD, et al. GeoSentinel surveillance of illness in returned travelers, 2007–2011. Ann Intern Med. 2013;158(6):456–68. Study with some recruitment bias but which provides information about ill returning travellers.

    Article  PubMed  Google Scholar 

  4. • Meece JK, Anderson JL, Gruszka S, Sloss BL, Sullivan B, Reed KD. Variation in clinical phenotype of human infection among genetic groups of Blastomyces dermatitidis. J Infect Dis. 2013;207(5):814–22. Advances in research on virulence mechanisms in fungi.

    Article  PubMed  CAS  Google Scholar 

  5. • Chang P, Rodas C. Skin lesions in histoplasmosis. Clin Dermatol. 2012;30(6):592–8. Dermatological aspects of histoplasmosis.

    Article  PubMed  Google Scholar 

  6. •• Byrnes 3rd EJ, Li W, Ren P, et al. A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients. PLoS Pathog. 2013;7(9):e1002205. A seminal study on pathogeny of C. gattii.

    Article  Google Scholar 

  7. •• Chen SC, Korman TM, Slavin MA, et al. Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clin Infect Dis. 2013;57(4):543–51. Very informative study of the demographics, clinical data, outcome and treatment of C. gattii.

    Article  PubMed  CAS  Google Scholar 

  8. •• Chen SC, Slavin MA, Heath CH, et al. Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death. Clin Infect Dis. 2012;55(6):789–98. Very informative study of the demographics, clinical data, outcome and treatment of C. gattii.

    Article  PubMed  Google Scholar 

  9. Vikram HR, Smilack JD, Leighton JA, Crowell MD, De Petris G. Emergence of gastrointestinal basidiobolomycosis in the United States, with a review of worldwide cases. Clin Infect Dis. 2012;54(12):1685–91.

    Article  PubMed  Google Scholar 

  10. Theodoro RC, Teixeira MM, Felipe MS, et al. Genus paracoccidioides: species recognition and biogeographic aspects. PLoS One. 2012;7(5):e37694.

    Article  PubMed  CAS  Google Scholar 

  11. •• Fisher MC, Henk DA, Briggs CJ, et al. Emerging fungal threats to animal, plant and ecosystem health. Nature. 2012;484(7393):186–94. Very comprehensive review on interactions between fungal disease and ecosystems.

    Article  PubMed  CAS  Google Scholar 

  12. • Systemic mycoses. Clin Dermatol. 2012;30(6):563–684. doi:10.1016/S0738-081X(12)00195-2. Special issue on dermatological involvement in deep mycosis.

  13. • Subcutaneous mycoses. Clin Dermatol. 2012;30(4):367–468. doi:10.1016/S0738-081X(12)00088-0. Special issue on dermatological involvement in superficial mycosis.

  14. • Smith JA, Kauffman CA. Pulmonary fungal infections. Respirology. 2012;17(6):913–26.

    Article  PubMed  Google Scholar 

  15. Romeo O, Scordino F, Chillemi V, Criseo G. Cryptococcus neoformans/Cryptococcus gattii species complex in southern Italy: an overview on the environmental diffusion of serotypes, genotypes and mating-types. Mycopathologia. 2012;174(4):283–91.

    Article  PubMed  Google Scholar 

  16. •• Hagen F, Colom MF, Swinne D, et al. Autochthonous and dormant Cryptococcus gattii infections in Europe. Emerg Infect Dis. 2012;18(10):1618–24. Comprehensive study about C. gattii infection in Europe and evidence of autochtonous strains.

    Article  PubMed  Google Scholar 

  17. Permpalung N, Kaewpoowat Q, Prasidthrathsint K, Chongnarungsin D, Hyman CL. Pulmonary blastomycosis: a new endemic area in New York state. Mycoses. 2013. doi:10.1111/myc.12073.

    PubMed  Google Scholar 

  18. Litvinov IV, St-Germain G, Pelletier R, Paradis M, Sheppard DC. Endemic human blastomycosis in Quebec, Canada, 1988–2011. Epidemiol Infect. 2013;141(6):1143–7.

    Article  PubMed  CAS  Google Scholar 

  19. Centers for Disease Control and Prevention (CDC). Increase in reported coccidioidomycosis – United States, 1998–2011. MMWR Morb Mortal Wkly Rep. 2013;62(12):217–21.

    Google Scholar 

  20. Marsden-Haug N, Goldoft M, Ralston C, et al. Coccidioidomycosis acquired in Washington State. Clin Infect Dis. 2012;56(6):847–50.

    Article  PubMed  Google Scholar 

  21. Brillhante RS, Moreira Filho RE, Rocha MF, et al. Coccidioidomycosis in armadillo hunters from the state of Ceara, Brazil. Mem Inst Oswaldo Cruz. 2012;107(6):813–5.

    Article  PubMed  Google Scholar 

  22. Silva MB, Costa MM, Torres CC, et al. Urban sporotrichosis: a neglected epidemic in Rio de Janeiro, Brazil. Cad Saude Publica. 2012;28(10):1867–80.

    Article  PubMed  Google Scholar 

  23. Calanni LM, Perez R, Brasili S, et al. Outbreak of histoplasmosis in Province of Neuquen, Patagonia Argentina. Rev Iberoam Micol. 2012. doi:10.1016/j.riam.2012.12.007.

    Google Scholar 

  24. Pan B, Chen M, Pan W, Liao W. Histoplasmosis: a new endemic fungal infection in China? review and analysis of cases. Mycoses. 2013;56(3):212–21.

    Article  PubMed  Google Scholar 

  25. Hu Y, Zhang J, Li X, et al. Penicillium marneffei infection: an emerging disease in mainland China. Mycopathologia. 2013;175(1–2):57–67.

    Article  PubMed  Google Scholar 

  26. Neblett Fanfair R, Benedict K, Bos J, et al. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med. 2012;367(23):2214–25.

    Article  PubMed  Google Scholar 

  27. • Cao C, Liang L, Wang W, et al. Common reservoirs for Penicillium marneffei infection in humans and rodents, China. Emerg Infect Dis. 2011;17(2):209–14. Very smart study with the aim of clarifying the physiopathology and natural cycle of P. marneffei.

    Article  PubMed  Google Scholar 

  28. Chandran V, Sadanandan SM, Sobhanakumari K. Chromoblastomycosis in Kerala, India. Indian J Dermatol Venereol Leprol. 2012;78(6):728–33.

    Article  PubMed  Google Scholar 

  29. Cordeiro Rde A, e Silva KR, Brilhante RS, et al. Coccidioides posadasii infection in bats, Brazil. Emerg Infect Dis. 2012;18(4):668–70.

    PubMed  Google Scholar 

  30. Pal DK, Mallick AA, Majhi TK, Biswas BK, Chowdhury MK. Rhinosporidiosis in southwest Bengal. Trop Dr. 2012;42(3):150–3.

    Article  Google Scholar 

  31. Apisarnthanarak A, Khawcharoenporn T, Thongphubeth K, et al. Postflood pseudofungemia due to Penicillium species. Clin Infect Dis. 2012;55(2):e9–e11.

    Article  PubMed  Google Scholar 

  32. Arantes TD, Theodoro RC, Da Graca Macoris SA, Bagagli E. Detection of Paracoccidioides spp. in environmental aerosol samples. Med Mycol. 2013;51(1):83–92.

    Article  PubMed  CAS  Google Scholar 

  33. Baddley JW, Winthrop KL, Patkar NM, et al. Geographic distribution of endemic fungal infections among older persons, United States. Emerg Infect Dis. 2011;17(9):1664–9.

    Article  PubMed  Google Scholar 

  34. Hassan HA, Majid RA, Rashid NG, et al. Eosinophilic granulomatous gastrointestinal and hepatic abscesses attributable to basidiobolomycosis and fasciolias: a simultaneous emergence in Iraqi Kurdistan. BMC Infect Dis. 2013;13:91.

    Article  PubMed  Google Scholar 

  35. Li AS, Pan WH, Wu SX, et al. Ecological surveys of the Cryptococcus species complex in China. Chin Med J (Engl). 2012;125(3):511–6.

    Google Scholar 

  36. Colom MF, Hagen F, Gonzalez A, et al. Ceratonia siliqua (carob) trees as natural habitat and source of infection by Cryptococcus gattii in the Mediterranean environment. Med Mycol. 2012;50(1):67–73.

    Article  PubMed  Google Scholar 

  37. Chowdhary A, Randhawa HS, Boekhout T, Hagen F, Klaassen CH, Meis JF. Temperate climate niche for Cryptococcus gattii in Northern Europe. Emerg Infect Dis. 2012;18(1):172–4.

    Article  PubMed  Google Scholar 

  38. Sellers B, Hall P, Cine-Gowdie S, et al. Cryptococcus gattii: an emerging fungal pathogen in the southeastern United States. Am J Med Sci. 2012;343(6):510–1.

    Article  PubMed  Google Scholar 

  39. Marr KA. Cryptococcus gattii as an important fungal pathogen of western North America. Expert Rev Anti-Infect Ther. 2012;10(6):637–43.

    Article  PubMed  CAS  Google Scholar 

  40. Marques-da-Silva SH, Rodrigues AM, de Hoog GS, Silveira-Gomes F, Camargo ZP. Occurrence of Paracoccidioides lutzii in the Amazon region: description of two cases. Am J Trop Med Hyg. 2012;87(4):710–4.

    Article  PubMed  Google Scholar 

  41. de Hoog GS, van Diepeningen AD, el Mahgoub S, van de Sande WW. New species of Madurella, causative agents of black-grain mycetoma. J Clin Microbiol. 2012;50(3):988–94.

    Article  PubMed  Google Scholar 

  42. Mhmoud NA, Ahmed SA, Fahal AH, de Hoog GS, Gerrits van den Ende AH, van de Sande WW. Pleurostomophora ochracea, a novel agent of human eumycetoma with yellow grains. J Clin Microbiol. 2012;50(9):2987–94.

    Article  PubMed  CAS  Google Scholar 

  43. Harris J, Lockhart S, Chiller T. Cryptococcus gattii: where do we go from here? Med Mycol. 2012;50(2):113–29.

    Article  PubMed  Google Scholar 

  44. Springer DJ, Phadke S, Billmyre B, Heitman J. Cryptococcus gattii, no longer an accidental pathogen? Curr Fungal Infect Rep. 2012;6(4):245–56.

    Article  PubMed  Google Scholar 

  45. Raffa RB, Eltoukhy NS, Raffa KF. Implications of climate change (global warming) for the healthcare system. J Clin Pharm Ther. 2012;37(5):502–4.

    Article  PubMed  CAS  Google Scholar 

  46. Bulterys PL, Le T, Quang VM, Nelson KE, Lloyd-Smith JO. Environmental predictors and incubation period of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Vietnam. Clin Infect Dis. 2013;56(9):1273–9.

    Article  PubMed  Google Scholar 

  47. Lanternier F, Dannaoui E, Morizot G, et al. A global analysis of mucormycosis in France: the RetroZygo Study (2005–2007). Clin Infect Dis. 2012;54 Suppl 1:S35–43.

    Article  PubMed  CAS  Google Scholar 

  48. Weddle G, Gandy K, Bratcher D, Pahud B, Jackson MA. Apophysomyces trapeziformis infection associated with a tornado-related injury. Pediatr Infect Dis J. 2012;31(6):640–2.

    Article  PubMed  Google Scholar 

  49. Angelini A, Drago G, Ruggieri P. Post-tsunami primary Scedosporium apiospermum osteomyelitis of the knee in an immunocompetent patient. Int J Infect Dis. 2013;17(8):e646–9.

    Article  PubMed  Google Scholar 

  50. Oliveira GG, Navarro IT, Freire RL, et al. Serological survey of Paracoccidioidomycosis in sheep. Mycopathologia. 2012;173(1):63–8.

    Article  PubMed  Google Scholar 

  51. • Ngamskulrungroj P, Chang Y, Sionov E, Kwon-Chung KJ. The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model. MBio. 2012;3(3). Provides important insights in the pathogenesis of C. neoformans and C. gattii.

  52. Trivedi SR, Sykes JE, Cannon MS, et al. Clinical features and epidemiology of cryptococcosis in cats and dogs in California: 93 cases (1988–2010). J Am Vet Med Assoc. 2011;239(3):357–69.

    Article  PubMed  Google Scholar 

  53. • McClelland EE, Hobbs LM, Rivera J, et al. The role of host gender in the pathogenesis of Cryptococcus neoformans infections. PLoS One. 2013;8(5):e63632. With reference 34, two interesting studies exploring the mechanisms of cryptococcal disease.

    Article  PubMed  CAS  Google Scholar 

  54. Bratton EW, El Husseini N, Chastain CA, et al. Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant. PLoS One. 2012;7(8):e43582.

    Article  PubMed  CAS  Google Scholar 

  55. Fierer J, Burton DW, Haghighi P, Deftos LJ. Hypercalcemia in disseminated coccidioidomycosis: expression of parathyroid hormone-related peptide is characteristic of granulomatous inflammation. Clin Infect Dis. 2012;55(7):e61–6.

    Article  PubMed  CAS  Google Scholar 

  56. Abreu e Silva MA, Salum FG, Figueiredo MA, Cherubini K. Important aspects of oral paracoccidioidomycosis – a literature review. Mycoses. 2013;56(3):189–99.

    Article  PubMed  Google Scholar 

  57. Azenha MR, Caliento R, Brentegani LG, de Lacerda SA. A retrospective study of oral manifestations in patients with paracoccidioidomycosis. Braz Dent J. 2012;23(6):753–7.

    Article  PubMed  Google Scholar 

  58. de Abreu ESMA, Salum FG, Figueiredo MA, Lopes TG, da Silva VD, Cherubini K. Interrelationship of clinical, histomorphometric and immunohistochemical features of oral lesions in chronic paracoccidioidomycosis. J Oral Pathol Med. 2013;42(3):235–42.

    Article  Google Scholar 

  59. Agudelo CA, Restrepo CA, Molina DA, et al. Tuberculosis and histoplasmosis co-infection in AIDS patients. Am J Trop Med Hyg. 2012;87(6):1094–8.

    Article  PubMed  CAS  Google Scholar 

  60. Shahani L. Disseminated histoplasma and CMV infection presenting as subacute intestinal obstruction in an immunocompromised patient. BMJ Case Rep. 2012;2012.

  61. Lee PP, Chan KW, Lee TL, et al. Penicilliosis in children without HIV infection – are they immunodeficient? Clin Infect Dis. 2012;54(2):e8–e19.

    Article  PubMed  Google Scholar 

  62. Geramizadeh B, Foroughi R, Keshtkar-Jahromi M, Malek-Hosseini SA, Alborzi A. Gastrointestinal basidiobolomycosis, an emerging infection in the immunocompetent host: a report of 14 patients. J Med Microbiol. 2012;61(Pt 12):1770–4.

    Article  PubMed  Google Scholar 

  63. Brick KE, Drolet BA, Lyon VB, Galbraith SS. Cutaneous and disseminated blastomycosis: a pediatric case series. Pediatr Dermatol. 2013;30(1):23–8.

    Article  PubMed  Google Scholar 

  64. Sidamonidze K, Peck MK, Perez M, et al. Real-time PCR assay for identification of Blastomyces dermatitidis in culture and in tissue. J Clin Microbiol. 2012;50(5):1783–6.

    Article  PubMed  CAS  Google Scholar 

  65. Van Der Veer J, Lewis RJ, Emtiazjoo AM, Allen SD, Wheat LJ, Hage CA. Cross-reactivity in the Platelia aspergillus enzyme immunoassay caused by blastomycosis. Med Mycol. 2012;50(4):396–8.

    Article  Google Scholar 

  66. Thompson 3rd GR, Bays DJ, Johnson SM, Cohen SH, Pappagianis D, Finkelman MA. Serum (1->3)-beta-D-glucan measurement in coccidioidomycosis. J Clin Microbiol. 2012;50(9):3060–2.

    Article  PubMed  CAS  Google Scholar 

  67. Thompson GR, Sharma S, Bays DJ, et al. Coccidioidomycosis: adenosine deaminase levels, serologic parameters, culture results, and polymerase chain reaction testing in pleural fluid. Chest. 2013;143(3):776–81.

    Article  PubMed  Google Scholar 

  68. Espinel-Ingroff A, Aller AI, Canton E, et al. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother. 2012;56(11):5898–906.

    Article  PubMed  CAS  Google Scholar 

  69. Posteraro B, Vella A, Cogliati M, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for discrimination between molecular types of Cryptococcus neoformans and Cryptococcus gattii. J Clin Microbiol. 2012;50(7):2472–6.

    Article  PubMed  CAS  Google Scholar 

  70. Koepsell SA, Hinrichs SH, Iwen PC. Applying a real-time PCR assay for Histoplasma capsulatum to clinically relevant formalin-fixed paraffin-embedded human tissue. J Clin Microbiol. 2012;50(10):3395–7.

    Article  PubMed  CAS  Google Scholar 

  71. Riviere S, Denis B, Bougnoux ME, Lanternier F, Lecuit M, Lortholary O. Serum Aspergillus galactomannan for the management of disseminated histoplasmosis in AIDS. Am J Trop Med Hyg. 2012;87(2):303–5.

    Article  PubMed  Google Scholar 

  72. Vergidis P, Walker RC, Kaul DR, et al. False-positive Aspergillus galactomannan assay in solid organ transplant recipients with histoplasmosis. Transpl Infect Dis. 2012;14(2):213–7.

    Article  PubMed  CAS  Google Scholar 

  73. Millon L, Larosa F, Lepiller Q, et al. Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. Clin Infect Dis. 2013;56(10):e95–e101.

    Article  PubMed  CAS  Google Scholar 

  74. El Shamy ME, Fahal AH, Shakir MY, Homeida MM. New MRI grading system for the diagnosis and management of mycetoma. Trans R Soc Trop Med Hyg. 2012;106(12):738–42.

    Article  PubMed  Google Scholar 

  75. Bertoni TA, Perenha-Viana MC, Patussi EV, Cardoso RF, Svidzinski TI. Western blotting is an efficient tool for differential diagnosis of paracoccidioidomycosis and pulmonary tuberculosis. Clin Vaccine Immunol. 2012;19(11):1887–8.

    Article  PubMed  CAS  Google Scholar 

  76. Dias L, de Carvalho LF, Romano CC. Application of PCR in serum samples for diagnosis of paracoccidioidomycosis in the southern Bahia-Brazil. PLoS Negl Trop Dis. 2012;6(11):e1909.

    Article  PubMed  CAS  Google Scholar 

  77. Lackner M, de Hoog GS, Verweij PE, et al. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother. 2012;56(5):2635–42.

    Article  PubMed  CAS  Google Scholar 

  78. Liu X, Zhang Z, Hou B, et al. Rapid identification of Sporothrix schenckii in biopsy tissue by PCR. J Eur Acad Dermatol Venereol. 2012. doi:10.1111/jdv.12030.

    Google Scholar 

  79. Huang JY, Bristow B, Shafir S, Sorvillo F. Coccidioidomycosis-associated deaths, United States, 1990–2008. Emerg Infect Dis. 2012;18(11):1723–8.

    Article  PubMed  Google Scholar 

  80. Seitz AE, Prevots DR, Holland SM. Hospitalizations associated with disseminated coccidioidomycosis, Arizona and California, USA. Emerg Infect Dis. 2012;18(9):1476–9.

    Article  PubMed  Google Scholar 

  81. Azadeh N, Chang YH, Kusne S, et al. The impact of early and brief corticosteroids on the clinical course of primary pulmonary coccidioidomycosis. J Infect. 2013;67(2):148–55.

    Article  PubMed  Google Scholar 

  82. Levy ER, McCarty JM, Shane AL, Weintrub PS. Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series. Clin Infect Dis. 2013;56(11):1573–8.

    Article  PubMed  CAS  Google Scholar 

  83. Taroumian S, Knowles SL, Lisse JR, et al. Management of coccidioidomycosis in patients receiving biologic response modifiers or disease-modifying antirheumatic drugs. Arthritis Care Res (Hoboken). 2012;64(12):1903–9.

    Article  CAS  Google Scholar 

  84. Proia LA, Harnisch DO. Successful use of posaconazole for treatment of blastomycosis. Antimicrob Agents Chemother. 2012;56(7):4029.

    Article  PubMed  CAS  Google Scholar 

  85. Brilhante RS, Caetano EP, Sidrim JJ, et al. Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii. Mycoses. 2013;56(3):397–401.

    Article  PubMed  CAS  Google Scholar 

  86. Kloezen W, Meis JF, Curfs-Breuker I, Fahal AH, van de Sande WW. In vitro antifungal activity of isavuconazole against Madurella mycetomatis. Antimicrob Agents Chemother. 2012;56(11):6054–6.

    Article  PubMed  CAS  Google Scholar 

  87. van Belkum A, Fahal AH, van de Sande WW. In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine. Antimicrob Agents Chemother. 2011;55(4):1771–3.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

C. Richaud was supported in 2011 by a grant from Novartis.

D. Lebeaux was supported by a grant from the AXA research fund.

O. Lortholary is a member of the Merck Sharp & Dohme (MSD) board, is a consultant for Astellas and Gilead Sciences, and received speaker’s fees from MSD, Astellas, Gilead Sciences, and Pfizer.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Lebeaux.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richaud, C., Lebeaux, D. & Lortholary, O. Fungal Infections Associated with Travel. Curr Fungal Infect Rep 7, 311–319 (2013). https://doi.org/10.1007/s12281-013-0151-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12281-013-0151-0

Keywords

Navigation